Definitive Therapy for Oligometastatic Solid Malignancies

Clinical trial NCT01898962 · UNKNOWN

Trial details

NCT number: NCT01898962
Sponsor: Rocky Mountain Cancer Centers
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV or Recurrent Carcinoma or Sarcoma

Start date: 2005-12-01
Primary completion: 2018-12-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.